SPARCL1 sparkles new insight into corneal dystrophies

被引：0
|
作者：
Turunen, Joni A. [1 ,2 ,3 ]
机构：
[1] Biomedicum Helsinki, Folkhalsan Res Ctr, Eye Genet Grp, Helsinki, Finland
[2] Univ Helsinki, Dept Ophthalmol, Ophthalm Genet & Rare Eye Dis Serv, Helsinki, Finland
[3] Helsinki Univ Hosp, Helsinki, Finland
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2024年 / 32卷 / 12期
关键词：
D O I：
10.1038/s41431-024-01709-5
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1524 / 1525
页数：2
相关论文
共 50 条
  • [1] SPARCL1 sparkles new insight into corneal dystrophies (vol 32, pg 1524, 2024)
    Turunen, Joni A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024,
  • [2] Autosomal dominant stromal corneal dystrophy associated with a SPARCL1 missense variant
    Braddock, Freddie L.
    Gardner, Jessica C.
    Bhattacharyya, Nihar
    Sanchez-Pintado, Beatriz
    Costa, Marcos
    Zarouchlioti, Christina
    Szabo, Anita
    Liskova, Petra
    Cheetham, Michael E.
    Young, Robert D.
    Thaung, Caroline
    Davidson, Alice E.
    Tuft, Stephen J.
    Hardcastle, Alison J.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, : 1583 - 1589
  • [3] SPARCL1 suppresses metastasis in prostate cancer
    Xiang, Yuzhu
    Qiu, Qingchao
    Jiang, Ming
    Jin, Renjie
    Lehmann, Brian D.
    Strand, Douglas W.
    Jovanovic, Bojana
    DeGraff, David J.
    Zheng, Yi
    Yousif, Dina A.
    Simmons, Christine Q.
    Case, Thomas C.
    Yi, Jia
    Cates, Justin M.
    Virostko, John
    He, Xiusheng
    Jin, Xunbo
    Hayward, Simon W.
    Matusik, Robert J.
    George, Alfred L., Jr.
    Yi, Yajun
    MOLECULAR ONCOLOGY, 2013, 7 (06) : 1019 - 1030
  • [4] SPARCL1 DEREGULATED IN ENDOMETRIOSIS LESIONS
    Ferriani, R. A.
    Meola, J.
    Hidalgo, G. dos S.
    Rosa e Silva, J. C.
    Paz, C. C. P.
    FERTILITY AND STERILITY, 2010, 94 (04) : S203 - S204
  • [5] A novel autosomal dominant Corneal Stromal Dystrophy associated with a SPARCL1 missense variant
    Braddock, Freddie L.
    Pintado, Beatriz Sanchez
    Szabo, Anita
    Bhattacharyya, Nihar
    Mitchell, Samanta
    Thaung, Caroline
    Gardner, Jessica C.
    Davidson, Alice E.
    Tuft, Stephen J.
    Hardcastle, Alison J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [6] The oncogenic functions of SPARCL1 in bladder cancer
    Li, Changjiu
    Yuan, Hui
    Chen, Jun
    Shang, Kun
    He, Huadong
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (22)
  • [7] SPARCL1 a novel player in cancer biology
    Gagliardi, Filippo
    Narayanan, Ashwin
    Mortini, Pietro
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 109 : 63 - 68
  • [8] SPARCL1 is an angiocrine inhibitor of tumorigenesis in colorectal carcinoma
    Tenkerian, Clara
    Regensburger, Daniela
    Langer, Victoria
    Klingler, Anika
    Borau, Anne
    Sticht, Heinrich
    Ramming, Andreas
    Wohlfahrt, Thomas
    Schmid, Benjamin
    Meniel, Valerie
    Gruetzmann, Robert
    Britzen-Laurent, Nathalie
    Schellerer, Vera
    Stuerzl, Michael
    Naschberger, Elisabeth
    CANCER RESEARCH, 2019, 79 (13)
  • [9] Prognostic value of SPARCL1 in patients with colorectal cancer
    Han, Wei
    Cao, Fang
    Ding, Wei
    Gao, Xiao-Jiao
    Chen, Fang
    Hu, Yong-Wei
    Ding, Hou-Zhong
    ONCOLOGY LETTERS, 2018, 15 (02) : 1429 - 1434
  • [10] Effects of SPARCL1 on the proliferation and differentiation of sheep preadipocytes
    Xiao, Cheng
    Jin, Hai Guo
    Zhang, Li Chun
    Liu, Jian Qiang
    He, Ming
    Ma, Hui Hai
    Yu, Yong Sheng
    Cao, Yang
    ADIPOCYTE, 2021, 10 (01) : 658 - 669
12345